KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for National Health Investors (NHI) over the last 17 years, with Q2 2025 value amounting to $56.5 million.

  • National Health Investors' Capital Expenditures rose 47267.38% to $56.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $259.2 million, marking a year-over-year increase of 252767.08%. This contributed to the annual value of $138.1 million for FY2024, which is 26272.16% up from last year.
  • National Health Investors' Capital Expenditures amounted to $56.5 million in Q2 2025, which was up 47267.38% from $74.5 million recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Capital Expenditures registered a high of $128.3 million during Q4 2024, and its lowest value of $8000.0 during Q1 2021.
  • In the last 5 years, National Health Investors' Capital Expenditures had a median value of $38.1 million in 2023 and averaged $40.0 million.
  • In the last 5 years, National Health Investors' Capital Expenditures plummeted by 9999.0% in 2021 and then skyrocketed by 47267.38% in 2025.
  • National Health Investors' Capital Expenditures (Quarter) stood at $46.8 million in 2021, then tumbled by 96.82% to $1.5 million in 2022, then surged by 2459.21% to $38.1 million in 2023, then skyrocketed by 236.81% to $128.3 million in 2024, then crashed by 55.95% to $56.5 million in 2025.
  • Its Capital Expenditures was $56.5 million in Q2 2025, compared to $74.5 million in Q1 2025 and $128.3 million in Q4 2024.